R-spondin-2



R-spondin-2

Q1QQ1G2GG2N3NN3R4RR4W5WW5R6RR6R7RR7S8SS8K9KK9R10RR10A11AA11S12SS12Y13YY13V14VV14S15SS15N16NN16P17PP17I18II18C19CC19K20KK20G21GG21C22CC22L23LL23S24SS24C25CC25S26SS26K27KK27D28DD28N29NN29G30GG30C31CC31S32SS32R33RR33C34CC34Q35QQ35Q36QQ36K37KK37L38LL38F39FF39F40FF40F41FF41L42LL42R43RR43R44RR44E45EE45G46GG46M47MM47... and 175 more residue(s)...... and 175 more residue(s)

SMILES None
InChIKey None
Sequence QGNRWRRSKRASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYGECLHSCPSGYYGHRAPDMNRCARCRIENCDSCFSKDFCTKCKVGFYLHRGRCFDECPDGFAPLEETMECVEGCEVGHWSEWGTCSRNNRTCGFKWGLETRTRQIVKKPVKDTILCPTIAESRRCKMTMRHCPGGKRTPKAKEKRNKKKKRKLIERAQEQHSVFLATDRANQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

R-spondin-2

Q1QQ1G2GG2N3NN3R4RR4W5WW5R6RR6R7RR7S8SS8K9KK9R10RR10A11AA11S12SS12Y13YY13V14VV14S15SS15N16NN16P17PP17I18II18C19CC19K20KK20G21GG21C22CC22L23LL23S24SS24C25CC25S26SS26K27KK27D28DD28N29NN29G30GG30C31CC31S32SS32R33RR33C34CC34Q35QQ35Q36QQ36K37KK37L38LL38F39FF39F40FF40F41FF41L42LL42R43RR43R44RR44E45EE45G46GG46M47MM47... and 175 more residue(s)...... and 175 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.